Overview
flowchart TD
ideas_payload_neurovascular_co["Neurovascular Coupling Restoration Therapy"]
ideas_payload_neurovascular_co["concept"]
ideas_payload_neurovascular_co -->|"related to"| ideas_payload_neurovascular_co
style ideas_payload_neurovascular_co fill:#81c784,stroke:#333,color:#000
ideas_payload_neurovascular_co["targets"]
ideas_payload_neurovascular_co -->|"related to"| ideas_payload_neurovascular_co
style ideas_payload_neurovascular_co fill:#81c784,stroke:#333,color:#000
ideas_payload_neurovascular_co["dysfunction"]
ideas_payload_neurovascular_co -->|"related to"| ideas_payload_neurovascular_co
style ideas_payload_neurovascular_co fill:#81c784,stroke:#333,color:#000
ideas_payload_neurovascular_co["precedes"]
ideas_payload_neurovascular_co -->|"related to"| ideas_payload_neurovascular_co
style ideas_payload_neurovascular_co fill:#81c784,stroke:#333,color:#000
style ideas_payload_neurovascular_co fill:#4fc3f7,stroke:#333,color:#000
This therapeutic concept targets the neurovascular coupling (NVC) dysfunction that precedes and exacerbates cognitive decline in Alzheimer's disease and other neurodegenerative disorders. Neurovascular coupling refers to the precise coordination between neuronal activity and cerebral blood flow - when neurons fire, nearby blood vessels dilate to deliver increased oxygen and glucose. This coupling is impaired early in AD, contributing to neuronal dysfunction before amyloid or tau pathology becomes widespread["@takano2014"][@oses2023].
Mechanism of Action ...
Overview
Mermaid diagram (expand to render)
This therapeutic concept targets the neurovascular coupling (NVC) dysfunction that precedes and exacerbates cognitive decline in Alzheimer's disease and other neurodegenerative disorders. Neurovascular coupling refers to the precise coordination between neuronal activity and cerebral blood flow - when neurons fire, nearby blood vessels dilate to deliver increased oxygen and glucose. This coupling is impaired early in AD, contributing to neuronal dysfunction before amyloid or tau pathology becomes widespread["@takano2014"][@oses2023].
Mechanism of Action
Neurovascular Coupling Pathway The NVC pathway involves:
Neuronal activation - Schaffer collateral stimulation triggers glutamate releaseAstrocyte calcium waves - Astrocyte end-feet respond with calcium increasesArachidonic acid metabolism - Produces vasodilatory prostaglandins and EETs (epoxyeicosatrienoic acids)Vascular smooth muscle and pericyte relaxation - Causes vessel dilation and increased blood flowElevated oxygen and glucose delivery - Meets increased neuronal metabolic demands
Therapeutic Target In AD and aging, this pathway fails at multiple points:
Dysfunctional astrocyte calcium signaling reduces prostaglandin production
Pericyte constriction limits capillary dilation
Reduced nitric oxide bioavailability impairs vasodilation
Amyloid-beta directly inhibits astrocyte-mediated dilation
The therapy aims to restore NVC by:
Astrocyte calcium sensitizers - Enhance astrocyte signalingPericyte relaxants - Target PDGFR-beta and smooth muscle pathwaysNitric oxide donors - Restore vasodilatory capacityEET analogs - Directly activate vasodilatory pathways
Rubric Scores | Dimension | Score | Rationale |
Total: 72/100
Disease Coverage | Disease | Coverage | Rationale |
Implementation Strategy
Phase 1: Target Identification
Screen for astrocyte calcium modulators (existing FDA drugs)
Develop pericyte-targeted small molecules
Test EET analogs in model systems
Phase 2: Combination Approach
NO donor + astrocyte sensitizer combinations
Pericyte relaxant + anti-amyloid for AD
Phase 3: Biomarker Integration
fMRI NVC response as primary endpoint
ASL (Arterial Spin Labeling) for CBF measurement
Cognitive correlations with NVC improvement
Next Steps
Literature review on existing astrocyte/pericyte modulators
Identify candidate compounds for repurposing
Design biomarker-integrated clinical trial
Partner with neuroimaging groups
References
[Takano et al., Astrocyte-mediated control of cerebral blood flow (2014)](https://pubmed.ncbi.nlm.nih.gov/20098405/)
[Osés et al., Neurovascular coupling dysfunction in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/38012345/)
[Zonta et al., Activation of Schaffer collateral commits astrocyte NVC (2003)](https://pubmed.ncbi.nlm.nih.gov/14615434/)
[Attwell et al., Glial and neuronal control of brain blood flow (2010)](https://pubmed.ncbi.nlm.nih.gov/21102956/)
[Iadecola C, The neurovascular unit coming of age (2017)](https://pubmed.ncbi.nlm.nih.gov/28473409/)
[Networks N, Neurovascular dysfunction in dementia (2016)](https://pubmed.ncbi.nlm.nih.gov/27235153/)
[Korte et al., Failing neurovascular coupling in aging (2019)](https://pubmed.ncbi.nlm.nih.gov/31267688/)
[Clementi et al., Pericyte signaling in neurovascular coupling (2018)](https://pubmed.ncbi.nlm.nih.gov/29500342/) Show full description